EARN25

Celgene Corporation (CELG) Call Buyers Still Waiting for a Breakout

Celgene Corporation (NASDAQ:CELG) isn't moving much, despite the firm's agreement to collaborate with Juno Therapeutics Inc (NASDAQ:JUNO) on immunotherapy research

Jun 30, 2015 at 3:00 PM
    facebook X logo linkedin


    Celgene Corporation (NASDAQ:CELG) is sitting out the rally among biopharmaceutical stocks, despite the company inking a 10-year deal with Juno Therapeutics Inc (NASDAQ:JUNO) to develop immunotherapy treatments. Specifically, while JUNO has surged over 16%, CELG is up a mere 0.6% at $115.57 -- disappointing news for option bulls.

    During the last four weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open 2.44 CELG calls for every put. To put that in perspective, the ratio was a more modest 1.45 at the end of May. In other words, bullish betting has picked up in recent weeks.

    The brokerage bunch is also exceedingly optimistic. Thirteen analysts currently rate CELG a "buy" or better, compared to three "holds" and not a single "sell." Plus, the stock's consensus 12-month price target of $137.15 stands in never-before-seen territory.

    On the charts, Celgene Corporation (NASDAQ:CELG) has struggled to break out of the $120-$122 neighborhood in recent months. Along similar lines, the stock has given back 10.5% since touching a record high of $129.06 in late March -- though it's currently found a foothold atop its 40-day moving average, located at $114.24.
     

    You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

    That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

    Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

    It’s not just a signal.

    It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

    No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

    👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!